CIBC Asset Management Inc grew its position in Agilent Technologies, Inc. (NYSE:A – Free Report) by 67.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 66,544 shares of the medical research company’s stock after purchasing an additional 26,698 shares during the period. CIBC Asset Management Inc’s holdings in Agilent Technologies were worth $9,055,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Core Wealth Advisors LLC bought a new position in Agilent Technologies in the 4th quarter worth about $26,000. Board of the Pension Protection Fund bought a new position in Agilent Technologies in the 4th quarter worth about $27,000. Navalign LLC bought a new position in Agilent Technologies in the 4th quarter worth about $27,000. Entrust Financial LLC acquired a new stake in shares of Agilent Technologies in the 4th quarter worth approximately $31,000. Finally, Torren Management LLC acquired a new stake in shares of Agilent Technologies in the 4th quarter worth approximately $32,000.
Agilent Technologies Stock Performance
Shares of A opened at $135.51 on Friday. The company’s fifty day moving average is $118.35 and its 200-day moving average is $128.35. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $160.27. The firm has a market cap of $38.27 billion, a price-to-earnings ratio of 27.21, a price-to-earnings-growth ratio of 2.46 and a beta of 1.26. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43.
Agilent Technologies Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be issued a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio is currently 20.48%.
Wall Street Analysts Forecast Growth
A has been the subject of a number of research analyst reports. Bank of America raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and reduced their price target for the stock from $150.00 to $145.00 in a research note on Thursday, May 28th. Barclays upped their price target on shares of Agilent Technologies from $140.00 to $145.00 and gave the stock an “overweight” rating in a research note on Thursday, May 28th. HSBC reduced their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Wednesday. Wolfe Research reaffirmed a “hold” rating on shares of Agilent Technologies in a research note on Tuesday. Finally, Wells Fargo & Company reduced their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $161.71.
Get Our Latest Stock Analysis on A
Agilent Technologies Profile
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
See Also
- Five stocks we like better than Agilent Technologies
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
